swk holdings corporation is focused on becoming a market leading innovator in healthcare finance by providing capital to a broad range of life science companies, institutions and inventors. swk’s primary focus is on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. the company believes its financing structures achieve an optimal partnership for companies, institutions and inventors seeking capital for expansion or capital and estate planning by allowing its partners to monetize future cash flow with minimal dilution to their equity stakes. swk funds transactions through its balance sheet as well as through its registered investment advisory subsidiary.